Download PDF
1 / Pages

Other users also viewed these articles

Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis S.M. Touhidul Islam; Jeseong Won; Mushfiquddin Khan; Kenneth D. Chavin; Inderjit Singh;
Ann Hepatol. 2020;19:466-71
A multisociety Delphi consensus statement on new fatty liver disease nomenclature Mary E. Rinella; Jeffrey V. Lazarus; Vlad Ratziu; Sven M. Francque; Arun J. Sanyal; Fasiha Kanwal; Diana Romero; Manal F. Abdelmalek; Quentin M. Anstee; Juan Pablo Arab; Marco Arrese; Ramon Bataller; Ulrich Beuers; Jerome Boursier; Elisabetta Bugianesi; Christopher D. Byrne; Graciela E. Castro Narro; Abhijit Chowdhury; Helena Cortez-Pinto; Donna R. Cryer; Kenneth Cusi; Mohamed El-Kassas; Samuel Klein; Wayne Eskridge; Jiangao Fan; Samer Gawrieh; Cynthia D. Guy; Stephen A. Harrison; Seung Up Kim; Bart G. Koot; Marko Korenjak; Kris V. Kowdley; Florence Lacaille; Rohit Loomba; Robert Mitchell-Thain; Timothy R. Morgan; Elisabeth E. Powell; Michael Roden; Manuel Romero-Gómez; Marcelo Silva; Shivaram Prasad Singh; Silvia C. Sookoian; C. Wendy Spearman; Dina Tiniakos; Luca Valenti; Miriam B. Vos; Vincent Wai-Sun Wong; Stavra Xanthakos; Yusuf Yilmaz; Zobair Younossi; Ansley Hobbs; Marcela Villota-Rivas; Philip N. Newsome;
Ann Hepatol. 2024;29:
Prognostic significance of low hepatic fat content in advanced chronic liver disease: MRI-PDFF insights Atsushi Nakamura; Tsubasa Yoshimura; Takeshi Ichikawa; Keiji Okuyama;
10.1016/j.aohep.2024.101507